Pioglitazone hydrochloride
Pioglitazone Hydrochloride
Pioglitazone Hydrochloride (pronunciation: pye-oh-GLI-ta-zone HYE-droe-KLOR-ide) is an oral anti-hyperglycemic agent that acts primarily by decreasing insulin resistance. It is used in the management of type 2 diabetes.
Etymology
The term "Pioglitazone" is derived from the chemical name "5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione hydrochloride". The suffix "-azone" is common in drugs that are thiazolidinediones, which are a class of medications used in the treatment of type 2 diabetes.
Usage
Pioglitazone Hydrochloride is used along with diet and exercise, and sometimes with other medications, to treat type 2 diabetes. It works by increasing the body's sensitivity to insulin, a natural substance that helps control blood sugar levels.
Related Terms
- Insulin Resistance: A condition in which the body's cells become resistant to the effects of insulin.
- Type 2 Diabetes: A chronic condition that affects the way the body processes blood sugar (glucose).
- Thiazolidinediones: A class of medications used in the treatment of type 2 diabetes.
- Hyperglycemia: An excess of glucose in the bloodstream, often associated with diabetes mellitus.
Side Effects
Common side effects of Pioglitazone Hydrochloride include headache, muscle pain, sore throat, weight gain, and changes in vision. Serious side effects can include new or worsening heart failure, bladder cancer, and liver problems.
Precautions
Before taking Pioglitazone Hydrochloride, patients should inform their healthcare provider if they have a history of heart disease, liver disease, or bladder cancer. It is also important to manage any side effects and monitor blood sugar levels regularly.
External links
- Medical encyclopedia article on Pioglitazone hydrochloride
- Wikipedia's article - Pioglitazone hydrochloride
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski